Anesthesiologist Raynaldo Rivera Ortiz Jr., MD, has pleaded not guilty to allegations he injected heart-stopping drugs into IV bags at Baylor Scott & White Surgicare North Dallas, Fox 4 KDFW reported Oct. 15.
Category: ROOT
Hospital finances need ‘intensive care,’ Ohio leader says
Ohio Hospital Association president and CEO Mike Abrams said hospital finances “need intensive care to rebound from COVID-19,” in an Oct. 16 opinion piece published on Cleveland.com.
13 gastroenterology updates
Here are 13 gastroenterology updates Becker’s has reported on since Oct. 4:
AI eye screening company receives $26M in funding
Artificial intelligence eye screening company Eyenuk secured $26 million in series A funding led by alternative investment firm AXA IM Alts, bringing its total funding to $43 million.
Atrium Health names Dr. Ebony Boulware chief science officer
Charlotte, N.C.-based Atrium Health has appointed Ebony Boulware, MD, as vice chief academic officer and chief science officer, the health system said Oct. 17.
Atrium Health names Dr. Ebony Boulware chief science officer
Charlotte, N.C.-based Atrium Health has appointed Ebony Boulware, MD, as vice chief academic officer and chief science officer, the health system said Oct. 17.
Female physician compensation: 11 facts
Female physician compensation for specialists grew 8.5 percent in the last year, according to data from Medscape’s 2022 female physician compensation report.
Dr. Henri Lamothe named CMO of 2 Upper Allegheny Health System hospitals
Henri Lamothe, MD, has been named chief medical officer of Olean, N.Y.-based Upper Allegheny Health System’s Bradford (Pa.) Regional Medical Center and Olean (N.Y.) General Hospital. Dr. Lamothe had been serving as CMO in an interim capacity since June…
Moffitt Cancer Center names new CIO
Tampa, Fla.-based Moffitt Cancer Center has hired Joyce Oh as vice president and CIO. She will oversee health IT and help with digital transformation efforts.
Cancer vaccine could be ready by 2030, BioNTech founders say
Personalized cancer vaccines are a few years away from regulators’ approval and being available for the public, BioNTech co-founders Uğur Şahin, MD, PhD, and Özlem Türeci, MD, told the BBC Oct. 16.
